Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
基本信息
- 批准号:7037236
- 负责人:
- 金额:$ 37.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-29 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS therapyalternative medicineantioxidantsantiviral agentsascorbatebiological signal transductionchemopreventionendothelinenzyme activityfree radical oxygengap junctionsgene expressionginkgo bilobahuman immunodeficiency virushuman tissuenitric oxide synthaseoxidative stresspharmacokineticsprostaglandinspulmonary hypertensionrespiratory epitheliumswinetissue /cell culturetocopherolsvascular endothelium permeabilityvasomotion
项目摘要
DESCRIPTION (provided by applicant): The incidence of HIV-related pulmonary hypertension has been recognized in the last few years with increasing frequency. However, the etiology and underlying molecular mechanisms of this serious complication are unknown. Recent clinical reports indicate that highly active antiretroviral therapy (HAART) may increase the incidence of HIV-related pulmonary hypertension. Our preliminary data have demonstrated that some HAART drugs impaired endothelium-dependent vasorelaxation, reduced the expression of endothelial nitric oxide synthase (eNOS), and increased super oxide anion production in porcine pulmonary arteries in vitro. In addition, some HAART drugs increased endothelial permeability and oxidative stress, and decreased the expression of several junctional molecules inhuman pulmonary artery endothelial cells (HPAECs). Furthetntore, ginsenoside Rbl and ginkgolide A effectively blocked some HAART drug-induced endothelial dysfunction. Based on these studies, we have developed our central hypotheses that some HAART drugs may cause endothelial dysfunction and oxidative stress in pulmonary arteries through unique molecular pathways, and ginseng and ginkgo compounds may effectively block these detrimental effects of HAART drugs on pulmonary arteries. Thus, we propose a multidisciplinary study to test these central hypotheses. Four specific aims are proposed.
Aim 1 is designed to determine the effect of HAART drugs on vasomotor activities and the eNOS system in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will investigate the vasomotor activities, eNOS expression, signal transduction pathways, and prostaglandin and endothelin systems.
Aim 2 is designed to determine the effect of HAART drugs on endothelial permeability, junction structures, and molecules in human pulmonary artery endothelial cells. We will investigate endothelial permeability, junction molecular expression, and regulation as well as signal transduction pathways.
Aim 3 is designed to determine the effect of HAART drugs on the reactive oxygen species (ROS) system in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will investigate the types and molecular sources of ROS production, the activities and gene expression of ROS-generating and internal antioxidant enzymes.
Aim 4 is designed to determine the effect of ginseng and ginkgo compounds on HAART drug induced-endothelial dysfunction and oxidative stress in porcine pulmonary arteries and human pulmonary artery endothelial cells. We will study whether ginseng and ginkgo compounds can block some HAART drug-induced vasomotor dysfunction and permeability increase as well as oxidative stress and related gene expression and regulation. The differences of ginseng and ginkgo compounds will be compared with vitamins C and E in blocking HAART-induced endothelial dysfunction.
This study will elucidate the molecular mechanisms of HAART drugs' action on pulmonary endothelial cells and provide valuable information for the development of effective strategies for the prevention and treatment of HIV-related pulmonary hypertension.
描述(由申请人提供):近年来,hiv相关肺动脉高压的发病率越来越高。然而,这种严重并发症的病因和潜在的分子机制尚不清楚。最近的临床报告表明,高效抗逆转录病毒治疗(HAART)可能会增加hiv相关肺动脉高压的发病率。我们的初步数据表明,在体外实验中,一些HAART药物损害了内皮依赖性血管松弛,降低了内皮型一氧化氮合酶(eNOS)的表达,并增加了猪肺动脉中超氧负离子的产生。此外,一些HAART药物增加了内皮通透性和氧化应激,降低了几种连接分子非肺动脉内皮细胞(hpaec)的表达。此外,人参皂苷Rbl和银杏内酯A可有效阻断HAART药物诱导的部分内皮功能障碍。基于这些研究,我们提出了我们的中心假设,即一些HAART药物可能通过独特的分子途径引起肺动脉内皮功能障碍和氧化应激,而人参和银杏化合物可能有效阻断HAART药物对肺动脉的这些有害影响。因此,我们提出一项多学科研究来检验这些中心假设。提出了四个具体目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Changyi Chen其他文献
Changyi Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Changyi Chen', 18)}}的其他基金
Natural Substance Derivative DHNB is A Novel Xanthine Oxidase Inhibitor
天然物质衍生物DHNB是一种新型黄嘌呤氧化酶抑制剂
- 批准号:
8443691 - 财政年份:2013
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Symposium on Genetics and Genomics of Pancreatic Cancer
分子外科医生胰腺癌遗传学和基因组学研讨会
- 批准号:
7408620 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7343457 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8316269 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7902294 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
7676707 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Research Training on Vascular Disease
分子外科医生血管疾病研究培训
- 批准号:
8132897 - 财政年份:2008
- 资助金额:
$ 37.5万 - 项目类别:
Molecular Surgeon Symposium on Vascular Injury, Repair
分子外科医生血管损伤、修复研讨会
- 批准号:
7057158 - 财政年份:2005
- 资助金额:
$ 37.5万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7123488 - 财政年份:2005
- 资助金额:
$ 37.5万 - 项目类别:
Effects of HAART drugs on endothelial dysfunction of pu*
HAART药物对pu*内皮功能障碍的影响
- 批准号:
7250204 - 财政年份:2005
- 资助金额:
$ 37.5万 - 项目类别:
相似海外基金
Complementary and alternative medicine for drug-induced gingival overgrowth: inhibitory effect of TRPA1 channel by lutein
药物性牙龈增生的补充和替代医学:叶黄素对 TRPA1 通道的抑制作用
- 批准号:
23K09321 - 财政年份:2023
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Complementary alternative medicine contributes to attenuate orofacial pain: anesthetic and anti-inflammatory effects of phytochemical
补充替代医学有助于减轻口面部疼痛:植物化学物质的麻醉和抗炎作用
- 批准号:
22K10232 - 财政年份:2022
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Negotiating distinctions between conventional and alternative medicine in the English- and French-language Wikipedias
英语和法语维基百科中讨论传统医学和替代医学之间的区别
- 批准号:
AH/V013203/1 - 财政年份:2021
- 资助金额:
$ 37.5万 - 项目类别:
Research Grant
Systematic study on legal regulations for complementary and alternative medicine
补充替代医学法律法规的系统研究
- 批准号:
19K21680 - 财政年份:2019
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Contribution of complementary alternative medicine to the orthodontic tooth-movement induced inflammatory pain: a possible role of dietary constituent
补充替代医学对正畸牙齿移动引起的炎症性疼痛的贡献:饮食成分的可能作用
- 批准号:
19K10415 - 财政年份:2019
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Application of complementary and alternative medicine for breast cancer based on kinetic characteristics of food components
基于食物成分动力学特征的乳腺癌补充替代医学应用
- 批准号:
18K14416 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the Mechanism of Care Effectiveness Using Complementary and Alternative Medicine Material Detergent for Radiation Skin Damage
阐明补充和替代药物材料清洁剂对放射性皮肤损伤的护理效果机制
- 批准号:
18K17460 - 财政年份:2018
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Quality of clinical research papers on complementary and alternative medicine: evaluation with modified systematic reviews
补充和替代医学临床研究论文的质量:用修改后的系统评价进行评估
- 批准号:
17K08938 - 财政年份:2017
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Formulation for the Application of the Energy Therapy "Reiki" as Complementary and Alternative Medicine for Cancer Patient
应用能量疗法“灵气”作为癌症患者的补充和替代医学的配方
- 批准号:
16K15906 - 财政年份:2016
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Boundaries between Orthodox Medicine and Alternative Medicine
正统医学与替代医学之间的界限
- 批准号:
16K21422 - 财政年份:2016
- 资助金额:
$ 37.5万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




